Openbase오픈베이스
049480 · KOSDAQ · ₩049480 · 오픈베이스
₩1,833▼ ₩42 (2.24%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩61B | ₩58B | ₩94B | ₩51B | ₩48B | ₩40B | ₩101B | ₩52B |
| Cost of sales | ₩46B | ₩46B | ₩73B | ₩39B | ₩36B | ₩31B | ₩82B | ₩40B |
| Gross profit | ₩15B | ₩12B | ₩21B | ₩12B | ₩13B | ₩9.2B | ₩18B | ₩12B |
| Operating income | ₩3.2B | ₩309M | ₩6.1B | ₩1.7B | ₩1.9B | −₩1.8B | ₩5B | ₩1.7B |
| Net income | ₩4.7B | ₩1.8B | ₩4.8B | ₩1.4B | ₩2.7B | −₩1.4B | ₩8.5B | −₩3.1B |
| Net income to shareholders | ₩4.2B | ₩2.1B | ₩3.6B | ₩1.5B | ₩2.5B | −₩365M | ₩7.6B | −₩3.1B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩192B | ₩198B | ₩180B | ₩176B | ₩166B | ₩158B | ₩173B | ₩164B |
| Current assets | ₩133B | ₩135B | ₩116B | ₩115B | ₩104B | ₩96B | ₩108B | ₩91B |
| Cash and equivalents | ₩21B | ₩28B | ₩17B | ₩17B | ₩14B | ₩17B | ₩29B | ₩17B |
| Total liabilities | ₩88B | ₩98B | ₩81B | ₩82B | ₩73B | ₩69B | ₩81B | ₩75B |
| Current liabilities | ₩81B | ₩91B | ₩75B | ₩77B | ₩58B | ₩53B | ₩65B | ₩58B |
| Borrowings | ₩9.3B | ₩14B | ₩18B | ₩21B | ₩21B | ₩19B | ₩19B | ₩24B |
| Total equity | ₩105B | ₩100B | ₩99B | ₩94B | ₩93B | ₩90B | ₩92B | ₩90B |
| Shareholders' equity | ₩91B | ₩87B | ₩86B | ₩82B | ₩80B | ₩77B | ₩78B | ₩77B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩2.4B | ₩1.5B | ₩1.8B | ₩3.4B | −₩2.4B | −₩4B | ₩26B | ₩2B |
| Capital spending | ₩100M | ₩302M | ₩280M | ₩70M | ₩298M | ₩467M | ₩312M | ₩134M |
| Free cash flow | −₩2.5B | ₩1.2B | ₩1.5B | ₩3.3B | −₩2.7B | −₩4.5B | ₩26B | ₩1.8B |
| Dividends paid | ₩1.4B | −₩683M | ₩0 | ₩0 | ₩1.4B | −₩683M | ₩0 | ₩0 |
Consolidated where available. Amounts in won.
Also known as: Openbase / 오픈베이스 / 049480 / KRX:049480
Source: KRX statistical information